DAI-10 is as good as DAI-30 in schizophrenia
- 20 March 2012
- journal article
- research article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 22 (10), 747-750
- https://doi.org/10.1016/j.euroneuro.2012.02.008
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Augmenting Clozapine With SertindoleJournal of Clinical Psychopharmacology, 2012
- Effects of sertindole on cognition in clozapine‐treated schizophrenia patientsActa Psychiatrica Scandinavica, 2012
- Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophreniaSchizophrenia Research, 2012
- Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)European Neuropsychopharmacology, 2010
- Remission in schizophrenia: analysis in a naturalistic settingComprehensive Psychiatry, 2009
- Five‐year follow‐up during antipsychotic treatment: efficacy, safety, functional and social outcomeActa Psychiatrica Scandinavica, 2007
- The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised modelSchizophrenia Research, 2006
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychological Medicine, 1983